Free Trial

Shuttle Pharmaceuticals (SHPH) Competitors

Shuttle Pharmaceuticals logo
$3.92 +0.12 (+3.16%)
Closing price 04:00 PM Eastern
Extended Trading
$3.80 -0.12 (-3.04%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SHPH vs. THAR, ASBP, TRAW, LPCN, IBIO, NRSN, LGVN, PULM, MTEX, and NAII

Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Tharimmune (THAR), Aspire Biopharma (ASBP), Traws Pharma (TRAW), Lipocine (LPCN), iBio (IBIO), NeuroSense Therapeutics (NRSN), Longeveron (LGVN), Pulmatrix (PULM), Mannatech (MTEX), and Natural Alternatives International (NAII). These companies are all part of the "pharmaceutical products" industry.

Shuttle Pharmaceuticals vs. Its Competitors

Shuttle Pharmaceuticals (NASDAQ:SHPH) and Tharimmune (NASDAQ:THAR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Tharimmune, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.94
TharimmuneN/AN/A-$12.20M-$6.10-0.51

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 1.2% of Tharimmune shares are owned by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are owned by insiders. Comparatively, 25.6% of Tharimmune shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Shuttle Pharmaceuticals has a beta of -1.01, suggesting that its stock price is 201% less volatile than the S&P 500. Comparatively, Tharimmune has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500.

In the previous week, Shuttle Pharmaceuticals had 6 more articles in the media than Tharimmune. MarketBeat recorded 11 mentions for Shuttle Pharmaceuticals and 5 mentions for Tharimmune. Tharimmune's average media sentiment score of 0.52 beat Shuttle Pharmaceuticals' score of 0.17 indicating that Tharimmune is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Shuttle Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tharimmune
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Shuttle Pharmaceuticals' return on equity of -772.76% beat Tharimmune's return on equity.

Company Net Margins Return on Equity Return on Assets
Shuttle PharmaceuticalsN/A -772.76% -347.06%
Tharimmune N/A -1,239.20%-365.06%

Tharimmune has a consensus price target of $17.00, indicating a potential upside of 444.87%. Given Tharimmune's stronger consensus rating and higher probable upside, analysts clearly believe Tharimmune is more favorable than Shuttle Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shuttle Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Tharimmune
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Tharimmune beats Shuttle Pharmaceuticals on 8 of the 14 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHPH vs. The Competition

MetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.07M$2.64B$6.06B$10.53B
Dividend YieldN/A57.77%5.73%4.79%
P/E Ratio-0.9422.5685.0527.24
Price / SalesN/A754.19593.90135.46
Price / CashN/A174.0137.5761.53
Price / Book0.905.3612.676.74
Net Income-$9.15M$33.06M$3.32B$276.59M
7 Day Performance-6.67%0.71%0.50%0.86%
1 Month Performance9.19%10.16%9.42%8.17%
1 Year Performance-87.17%-0.86%79.11%43.66%

Shuttle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHPH
Shuttle Pharmaceuticals
0.7187 of 5 stars
$3.92
+3.2%
N/A-86.4%$4.07MN/A-0.945Analyst Forecast
THAR
Tharimmune
2.4626 of 5 stars
$3.02
-0.3%
$17.00
+462.9%
+46.9%$17.83MN/A-0.502Gap Down
ASBP
Aspire Biopharma
N/A$0.36
-6.7%
N/AN/A$17.79MN/A0.00N/AGap Down
TRAW
Traws Pharma
0.8143 of 5 stars
$2.50
+11.6%
N/A-44.4%$17.66M$2.90M0.0317News Coverage
LPCN
Lipocine
3.1481 of 5 stars
$3.22
+0.6%
$8.00
+148.4%
-39.5%$17.45M$11.20M-3.7010High Trading Volume
IBIO
iBio
1.8783 of 5 stars
$0.87
+2.3%
$5.00
+475.2%
-69.3%$17.09M$400K-0.50100
NRSN
NeuroSense Therapeutics
2.2657 of 5 stars
$1.15
-1.7%
$14.00
+1,117.4%
+8.0%$17.08MN/A-2.1310
LGVN
Longeveron
2.5947 of 5 stars
$0.81
+2.3%
$7.67
+847.7%
-55.3%$17.04M$2.39M-0.1320
PULM
Pulmatrix
0.9653 of 5 stars
$4.65
-8.1%
N/A+130.8%$16.97M$369K-2.1420Positive News
MTEX
Mannatech
0.9138 of 5 stars
$8.89
-1.2%
N/A+30.6%$16.90M$112.98M-4.36250News Coverage
Gap Down
NAII
Natural Alternatives International
1.5761 of 5 stars
$2.71
-1.8%
N/A-42.5%$16.75M$129.86M-1.19290Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners